ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,161,000 | -1.9% | 1,000,000 | 0.0% | 0.32% | +0.9% |
| Q2 2020 | $1,183,000 | -4.6% | 1,000,000 | 0.0% | 0.32% | -17.3% |
| Q1 2020 | $1,240,000 | -37.0% | 1,000,000 | -50.0% | 0.39% | -29.9% |
| Q4 2019 | $1,968,000 | +25.3% | 2,000,000 | 0.0% | 0.55% | +4.3% |
| Q3 2019 | $1,571,000 | -8.1% | 2,000,000 | 0.0% | 0.53% | -13.3% |
| Q2 2019 | $1,709,000 | -63.7% | 2,000,000 | -50.0% | 0.61% | -55.4% |
| Q1 2019 | $4,704,000 | – | 4,000,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |